GSK revenue and financials
In the fiscal year ended December 2025, GSK reported revenue of £32.67B (+4.11% year over year). Net income was £5.72B, a net margin of 17.5%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +4.11%
- 2025 vs 2024
- Net income growth
- +121.98%
- 2025 vs 2024
- Net margin
- 17.5%
- 2024: 8.2%
How GSK is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 6.0% a year on average over the last 5 years
Compound annual growth rate: from £24.35B in 2020 to £32.67B in 2025.
Revenue has grown for 5 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from 21.9% to 24.3%
Operating income over revenue, 2022 → 2025: 2.3 percentage points.
Profits turn into cash: free cash flow equal to 129% of net income
Totals for fiscal years 2023–2025: free cash flow £17B, net income £13.22B.
Financial data
Amounts in millions of GBP; per-share values in GBP; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 32,667 | 31,376 | 30,328 | 29,324 | 24,696 | 24,354 | 33,754 | 30,821 | 30,186 | 27,889 |
| Cost of revenue | 9,017 | 9,048 | 8,565 | 9,554 | 8,163 | 7,929 | 11,863 | 10,241 | 10,342 | 9,290 |
| Gross profit | 23,650 | 22,328 | 21,763 | 19,770 | 16,533 | 16,425 | 21,891 | 20,580 | 19,844 | 18,599 |
| Selling, general and administrative | 9,013 | 10,847 | 9,156 | 8,179 | 6,784 | 7,041 | 10,962 | 9,500 | 9,424 | 8,852 |
| Research and development | 7,525 | 6,401 | 6,223 | 5,488 | 5,019 | 4,793 | 4,568 | 3,893 | 4,476 | 3,628 |
| Operating income | 7,932 | 4,021 | 6,745 | 6,433 | 4,357 | 5,979 | 6,961 | 5,483 | 4,087 | 2,598 |
| EBIT | 9,447 | 6,190 | 8,403 | 7,322 | 5,634 | 6,050 | 8,201 | 7,495 | 6,721 | 5,288 |
| EBITDA | 11,335 | 8,319 | 10,507 | 9,293 | 7,756 | 8,100 | 10,321 | 9,351 | 8,643 | 7,062 |
| Interest expense | 701 | 669 | 792 | 879 | 769 | 874 | 912 | 798 | 734 | 736 |
| Pre-tax income | 7,401 | 3,477 | 6,064 | 5,628 | 3,599 | 5,170 | 6,221 | 4,800 | 3,525 | 1,939 |
| Income tax | 1,112 | 526 | 756 | 707 | 83.0 | 67.0 | 953 | 754 | 1,356 | 877 |
| Net income | 5,716 | 2,575 | 4,928 | 14,956 | 4,385 | 5,749 | 4,645 | 3,623 | 1,532 | 912 |
| Net income to common shareholders | 5,716 | 2,575 | 4,928 | 14,956 | 4,385 | 4,873 | 4,645 | 3,623 | 1,532 | 912 |
| Basic EPS | 1.41 | 0.63 | 1.22 | 3.71 | 1.10 | 1.44 | 0.94 | 0.74 | 0.31 | 0.19 |
| Diluted EPS | 1.39 | 0.62 | 1.20 | 3.66 | 1.08 | 1.43 | 0.93 | 0.73 | 0.31 | 0.19 |
| Average shares (basic) | 4,051 | 4,077 | 4,052 | 4,026 | 4,003 | 3,981 | 3,958 | 3,931 | 3,909 | 3,888 |
| Average shares (diluted) | 4,117 | 4,142 | 4,111 | 4,084 | 4,052 | 4,030 | 4,013 | 3,977 | 3,953 | 3,927 |
| Dividend per share | 0.66 | 0.61 | 0.58 | 0.61 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Amounts in millions of GBP; per-share values in GBP; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8,887 | 8,409 | 7,629 | 8,618 | 8,547 | 7,986 | 7,516 | 8,117 | 8,012 | 7,884 | 7,363 | 8,052 |
| Cost of revenue | 2,240 | 2,072 | 1,873 | 2,617 | 2,239 | 2,165 | 1,926 | 2,537 | 2,328 | 2,062 | 1,918 | 2,337 |
| Gross profit | 6,647 | 6,337 | 5,756 | 6,001 | 6,308 | 5,821 | 5,590 | 5,580 | 5,684 | 5,822 | 5,445 | 5,715 |
| Selling, general and administrative | 2,174 | 2,192 | 2,085 | 2,666 | 2,162 | 2,131 | 2,054 | 2,621 | 3,767 | 2,389 | 2,070 | 2,595 |
| Research and development | 1,904 | 1,747 | 1,518 | 2,138 | 1,575 | 1,544 | 1,397 | 1,836 | 1,441 | 1,428 | 1,373 | 1,799 |
| Operating income | 2,586 | 2,602 | 2,768 | 1,631 | 2,712 | 2,392 | 2,310 | 1,003 | 667 | 2,149 | 2,305 | 1,721 |
| EBIT | 2,586 | 2,602 | 2,768 | 1,631 | 2,712 | 2,392 | 2,310 | 1,003 | 667 | 2,149 | 2,305 | 1,721 |
| EBITDA | 3,327 | 2,825 | 3,231 | 2,689 | 3,338 | 3,011 | 3,133 | 1,849 | 1,618 | 2,788 | 2,854 | 1,951 |
| Interest expense | 219 | 182 | 167 | 145 | 167 | 184 | 162 | 120 | 155 | 174 | 166 | 146 |
| Pre-tax income | 1,935 | 354 | 2,144 | 950 | 2,456 | 1,887 | 2,108 | 563 | 64.0 | 1,495 | 1,355 | 379 |
| Income tax | 232 | -199 | 305 | 223 | 312 | 241 | 336 | 62.0 | -1.0 | 191 | 274 | -19.0 |
| Net income | 1,543 | 435 | 1,737 | 636 | 2,013 | 1,443 | 1,624 | 414 | -58.0 | 1,173 | 1,046 | 350 |
| Net income to common shareholders | 1,543 | 435 | 1,737 | 636 | 2,013 | 1,443 | 1,624 | 414 | -58.0 | 1,173 | 1,046 | 350 |
| Basic EPS | 0.38 | 0.11 | 0.43 | 0.16 | 0.50 | 0.36 | 0.40 | 0.10 | -0.01 | 0.29 | 0.26 | 0.09 |
| Diluted EPS | 0.38 | 0.11 | 0.43 | 0.16 | 0.49 | 0.35 | 0.39 | 0.10 | -0.01 | 0.29 | 0.25 | 0.09 |
| Average shares (basic) | 4,009 | 4,014 | 4,023 | 4,019 | 4,034 | 4,063 | 4,088 | 4,081 | 4,080 | 4,079 | 4,069 | 4,056 |
| Average shares (diluted) | 4,073 | 4,062 | 4,074 | 4,086 | 4,102 | 4,110 | 4,137 | 4,145 | 4,141 | 4,122 | 4,113 | 4,116 |
| Dividend per share | 0.17 | 0.17 | 0.17 | 0.18 | 0.16 | 0.16 | 0.16 | 0.16 | 0.15 | 0.15 | 0.15 | 0.16 |
Amounts in millions of GBP; per-share values in GBP; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 61,118 | 59,463 | 59,005 | 60,146 | 79,103 | 80,431 | 79,692 | 58,066 | 56,381 | 59,081 |
| Current assets | 17,510 | 16,997 | 18,644 | 20,769 | 18,674 | 20,247 | 19,491 | 16,927 | 15,907 | 16,711 |
| Cash and equivalents | 3,397 | 3,870 | 2,936 | 3,723 | 4,274 | 6,292 | 4,707 | 3,874 | 3,833 | 4,897 |
| Short-term investments | 9.0 | 21.0 | 42.0 | 67.0 | 614 | 480 | 786 | 419 | 78.0 | 89.0 |
| Receivables | 7,374 | 6,935 | 7,403 | 7,115 | 7,478 | 6,862 | 6,441 | 5,946 | 5,950 | 5,917 |
| Inventory | 5,924 | 5,669 | 5,498 | 5,146 | 5,783 | 5,996 | 5,947 | 5,476 | 5,557 | 5,102 |
| Net property, plant and equipment | 10,048 | 10,073 | 9,957 | 9,620 | 10,672 | 11,006 | 11,314 | 11,058 | 10,860 | 10,808 |
| Goodwill | 7,018 | 6,982 | 6,811 | 7,046 | 10,552 | 10,597 | 10,562 | 5,789 | 5,734 | 5,965 |
| Other intangible assets | 16,748 | 15,515 | 14,768 | 14,318 | 30,079 | 29,824 | 30,955 | 17,202 | 17,562 | 18,776 |
| Long-term investments | 1,126 | 1,196 | 1,192 | 1,541 | 2,276 | 3,496 | 2,276 | 1,563 | 1,109 | 1,248 |
| Current liabilities | 21,391 | 21,697 | 21,068 | 22,810 | 23,670 | 22,148 | 24,050 | 22,491 | 26,569 | 19,001 |
| Accounts payable | 3,535 | 3,462 | 3,718 | 3,866 | 4,535 | 4,357 | 4,144 | 3,645 | 3,528 | 3,596 |
| Long-term debt | 14,453 | 13,095 | 15,040 | 17,197 | 19,838 | 20,780 | 25,215 | 21,621 | 13,178 | 13,804 |
| Total debt | 16,709 | 16,986 | 17,203 | 19,498 | 23,467 | 26,104 | 25,540 | 21,662 | 16,327 | 17,404 |
| Total liabilities | 45,162 | 46,377 | 46,210 | 50,050 | 57,761 | 59,623 | 61,335 | 54,394 | 52,892 | 54,118 |
| Total equity (incl. minority) | 15,956 | 13,086 | 12,795 | 10,096 | 21,342 | 20,808 | 18,357 | 3,672 | 3,489 | 4,963 |
| Retained earnings | 10,957 | 8,767 | 7,743 | 4,792 | 8,747 | 7,294 | 5,054 | -2,701 | -6,920 | -5,264 |
| Minority interest | -421 | -585 | -552 | -502 | 6,287 | 6,221 | 6,952 | -109 | 3,557 | 3,839 |
Amounts in millions of GBP; per-share values in GBP; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 71,699 | 61,738 | 62,869 | 61,118 | 61,339 | 59,258 | 60,705 | 59,463 | 58,049 | 58,066 | 58,511 | 59,005 |
| Current assets | 17,895 | 17,559 | 17,761 | 17,510 | 17,842 | 17,673 | 18,085 | 16,997 | 17,298 | 16,764 | 17,205 | 18,644 |
| Cash and equivalents | 2,934 | 3,105 | 3,442 | 3,397 | 3,296 | 3,599 | 4,464 | 3,870 | 3,192 | 2,962 | 2,790 | 2,936 |
| Short-term investments | 28.0 | 1.0 | 1.0 | 9.0 | 10.0 | 20.0 | 21.0 | 21.0 | 20.0 | 21.0 | 1,305 | 42.0 |
| Receivables | 8,525 | 8,074 | 7,937 | 7,374 | 8,304 | 7,697 | 7,501 | 6,935 | 7,867 | 7,778 | 7,291 | 7,403 |
| Inventory | 6,300 | 6,282 | 6,157 | 5,924 | 6,118 | 6,072 | 6,000 | 5,669 | 5,918 | 5,859 | 5,702 | 5,498 |
| Net property, plant and equipment | 10,122 | 10,032 | 10,038 | 10,048 | 10,132 | 9,918 | 9,971 | 10,073 | 9,725 | 9,823 | 9,867 | 9,957 |
| Goodwill | 8,216 | 7,381 | 7,287 | 7,018 | 7,117 | 6,734 | 6,926 | 6,982 | 6,680 | 6,960 | 6,978 | 6,811 |
| Other intangible assets | 25,172 | 16,802 | 18,138 | 16,748 | 16,865 | 15,376 | 16,258 | 15,515 | 15,010 | 15,473 | 15,667 | 14,768 |
| Long-term investments | 863 | 955 | 958 | 1,126 | 1,083 | 977 | 1,032 | 1,196 | 1,104 | 1,152 | 1,277 | 1,192 |
| Current liabilities | 20,720 | 21,534 | 22,429 | 21,391 | 21,334 | 20,378 | 20,831 | 21,697 | 21,459 | 20,345 | 19,846 | 21,068 |
| Accounts payable | 15,633 | 14,342 | 14,210 | 3,535 | 14,551 | 13,648 | 13,840 | 3,462 | 13,473 | 13,327 | 13,707 | 3,718 |
| Long-term debt | 21,801 | 14,002 | 14,068 | 14,082 | 14,894 | 15,304 | 16,474 | 13,703 | 13,244 | 13,577 | 15,156 | 14,154 |
| Total debt | 23,701 | 14,002 | 18,869 | 16,709 | 17,213 | 17,079 | 18,219 | 16,986 | 15,895 | 16,860 | 17,570 | — |
| Total liabilities | 53,337 | 44,561 | 45,447 | 45,162 | 45,587 | 44,904 | 47,051 | 46,377 | 44,596 | 44,296 | 45,282 | 46,210 |
| Total equity (incl. minority) | 18,362 | 17,177 | 17,422 | 15,956 | 15,752 | 14,354 | 13,654 | 13,086 | 13,453 | 13,770 | 13,229 | 12,795 |
| Retained earnings | 12,458 | 11,464 | 11,590 | 10,957 | 10,016 | 8,797 | 8,307 | 8,767 | 8,187 | 8,583 | 7,935 | 7,743 |
| Minority interest | -392 | -468 | -430 | -421 | -396 | -437 | -503 | -585 | -555 | -602 | -611 | -552 |
Amounts in millions of GBP; per-share values in GBP; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 7,741 | 6,554 | 6,768 | 7,403 | 7,952 | 8,441 | 8,020 | 8,421 | 6,918 | 6,497 |
| Depreciation and amortization | 2,314 | 2,551 | 2,294 | 2,147 | 2,122 | 2,050 | 2,334 | 1,856 | 1,922 | 1,774 |
| Capital expenditure | -1,348 | -1,399 | -1,314 | -1,143 | -950 | -989 | -1,265 | -1,344 | -1,545 | -1,543 |
| Investing cash flow | -4,233 | -1,229 | -1,595 | -8,772 | -1,777 | 2,161 | -5,354 | -1,553 | -1,443 | -1,269 |
| Financing cash flow | -3,685 | -4,726 | -5,641 | 823 | -7,589 | -10,132 | -1,840 | -6,389 | -6,380 | -6,392 |
| Dividends paid | -2,564 | -2,444 | -2,247 | -3,467 | -3,999 | -3,977 | -3,953 | -3,927 | 3,906 | -3,881 |
| Share repurchases | -1,377 | 0.0 | 0.0 | — | — | — | — | — | -65.0 | -74.0 |
| Debt issued | 3,194 | 1,341 | 223 | 2,046 | 301 | 3,298 | 7,889 | 10,219 | 2,233 | 1,013 |
| Debt repaid | -1,929 | -2,733 | -2,790 | -6,870 | -2,485 | -7,514 | -4,374 | -2,095 | -3,223 | -883 |
| Effect of exchange rates | -19.0 | -54.0 | -99.0 | 152 | -29.0 | -39.0 | -82.0 | 8.0 | -100 | 283 |
| Net change in cash | -196 | 545 | -567 | -394 | -1,443 | 431 | 744 | 487 | -1,005 | -881 |
| Free cash flow | 6,393 | 5,155 | 5,454 | 6,260 | 7,002 | — | — | — | — | — |
| Levered free cash flow | 3,284 | 4,954 | 3,837 | 4,266 | 4,847 | 5,563 | 4,783 | -2,602 | 12,396 | 4,644 |
Amounts in millions of GBP; per-share values in GBP; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2,809 | 2,690 | 1,141 | 2,278 | 2,222 | 2,096 | 1,145 | 2,329 | 2,154 | 1,113 | 958 | 3,196 |
| Depreciation and amortization | 741 | 223 | 463 | -626 | 626 | 619 | 823 | 201 | 951 | 639 | 549 | 420 |
| Capital expenditure | -374 | -328 | -221 | -573 | -311 | -256 | -208 | -544 | -305 | -302 | -248 | -486 |
| Investing cash flow | -7,708 | -789 | -1,466 | -933 | -1,531 | -625 | -1,144 | -1,119 | -731 | 770 | -149 | 268 |
| Financing cash flow | 4,670 | -2,149 | 272 | -856 | -1,315 | -2,372 | 858 | -842 | -1,240 | -1,584 | -1,060 | -3,592 |
| Dividends paid | -682 | -727 | -643 | -646 | -650 | -656 | -612 | -612 | -612 | -652 | -568 | -568 |
| Share repurchases | 0.0 | -308 | -326 | -252 | -317 | -561 | -247 | — | — | — | — | — |
| Debt issued | 6,315 | 273 | 1,202 | 552 | -80.0 | 645 | 2,077 | 1,341 | — | — | — | -1,409 |
| Debt repaid | -939 | -958 | -73.0 | -79.0 | -62.0 | -1,572 | -216 | -1,153 | -604 | -596 | -380 | -1,410 |
| Effect of exchange rates | -34.0 | -7.0 | 2.0 | -41.0 | 59.0 | -26.0 | -11.0 | 7.0 | -34.0 | -8.0 | -19.0 | -34.0 |
| Net change in cash | -263 | -212 | -51.0 | 448 | -565 | -927 | 848 | 375 | 149 | 291 | -270 | -162 |
| Free cash flow | 2,435 | 2,362 | 920 | 1,705 | 1,911 | 1,840 | 937 | 1,785 | 1,849 | 811 | 710 | 2,710 |
| Levered free cash flow | 2,684 | 1,099 | 485 | 223 | 1,042 | 367 | 750 | 1,937 | 1,887 | 510 | 579 | 3,032 |
Financial statements of similar companies
Companies in the group: same industry, similar size
